TABLE 1:

Clinical data and results of sclerotherapy in group A

Group A	Age (y)/Sex	First Aspirates (ml)	Infused Ethanol (ml)	Total Procedure (min)	First Follow-up Ultrasonography (mo)	Therapeutic Result	Complication
1	39/F	2	2	14	2	+
2	51/F	7	7	15	1	+
3	49/M	2	2	15	8	+
4	44/F	5	5	17	15	+
5	37/F	10	7	16	15	+	Headache, dizziness
6	43/M	12	9	16	8	+
7	43/F	5	5	16	5	+
8	43/F	4	4	17	5	+	Mild pain
9	58/F	8	8	16	3	+	Moderate pain
10	36/F	6	6	15	15	+	Mild pain
11	44/M	15	10	18	3	+	Mild pain
12	27/F	7	6	15	7	+
13	38/F	5	5	17	3	+	Facial flushing
14	47/F	13	12	15	1	+	Mild pain
15	49/F	4	4	14	2	+
16	28/F	3.5	3.5	14	8	+
17	38/F	7	7	15	4	+
18	43/M	29	16	20	2	+
19	32/F	8	8	16	2	+	Intracystic hemorrhage
20	44/F	2	3	20	2	+	Mild pain
21	64/F	2	2	13	3	+	Mild pain
22	46/M	4	4	15	2	+
23	47/M	40	15	20	4	+
24	75/F	20	12	17	3	+
25	47/M	10	7	16	2	+
26	35/F	20	17	19	2	+	Mild pain
27	45/F	5	5	15	1	+	Mild pain, drunken sense
28	16/M	96	20	23	2	+	Facial flushing, drunken sense
29	70/F	135	30	29	3	+	Perithyroidal leakage
30	47/F	8	8	15	2	−
Mean	44.2	16.5	8.3	16.8	4.6

Note.—+ indicates complete disappearance of the cystic portion of the thyroid nodule; −, incomplete disappearance of the cystic portion of the thyroid nodule.